Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?

Drake Marcus J.

首页> 外文期刊>European urology >Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?

【24h】

Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?

机译：男性下泌尿道症状中磷酸二酯酶5型抑制剂的益处是否超过改善的症状？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2016年第1期|共2页
作者
Drake Marcus J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms? [J] . Drake Marcus J. European urology . 2016,第1期

机译：男性下泌尿道症状中磷酸二酯酶5型抑制剂的益处是否超过改善的症状？
2. Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence. [J] . Martinez Salamanca JI, Carballido J, Eardley I, European urology . 2011,第3期

机译：磷酸二酯酶5型抑制剂在非神经源性男性下尿路症状的治疗中：对当前证据的严格分析。
3. Phosphodiesterase Type 5 Inhibitors for the Treatment of Male Lower Urinary Tract Symptoms [J] . Steven A Kaplan, Ricardo R Gonzalez Reviews in Urology . 2007,第2期

机译：磷酸二酯酶5型抑制剂治疗男性下尿路症状
4. Combining DiLeu Isobaric Labeling and Label-free Approaches for Metabolite Quantification and Biomarker Discovery of Lower Urinary Tract Symptoms (LUTS) [C] . Ling Hao, Tyler Greer, Xuefei Zhong, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：结合Dileu Isobaric标记和标记的代谢物量化方法和患有低尿路症状的生物标记症状（LUT）
5. The association of caffeine intake with components of lower urinary tract symptoms (LUTS) among cancer survivors. [D] . Anan, Hadeel F. 2016

机译：癌症幸存者中咖啡因的摄入与下尿路症状（LUTS）的相关性。
6. Phosphodiesterase Type 5 Inhibitors for the Treatment of Male Lower Urinary Tract Symptoms [O] . Steven A Kaplan, Ricardo R Gonzalez 2007

机译：磷酸二酯酶5型抑制剂治疗男性下尿路症状
7. Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis [O] . Chengquan Ma, Jianzhong Zhang, Zhonglin Cai, 2020

机译：定义磷酸二磷酸酯蛋白酶型5抑制剂的疗效和安全性，用于治疗患有或不带勃起功能障碍的良性前列腺增生的下泌尿道症状：网络元分析

Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?

著录项

相似文献

相关主题

期刊订阅